Complement-dependent tumor cell lysis triggered by combinations of epidermal growth factor receptor antibodies. [electronic resource]
Producer: 20080805Description: 4998-5003 p. digitalISSN:- 1538-7445
- Antibodies -- administration & dosage
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Antibody-Dependent Cell Cytotoxicity -- physiology
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Caco-2 Cells
- Cell Death -- drug effects
- Cetuximab
- Complement System Proteins -- physiology
- Dose-Response Relationship, Drug
- Drug Evaluation, Preclinical
- Epitope Mapping
- ErbB Receptors -- immunology
- Humans
- Immunoglobulin A -- administration & dosage
- Immunoglobulin Fab Fragments -- administration & dosage
- Models, Biological
- Neoplasms -- drug therapy
- Panitumumab
- Tumor Cells, Cultured
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.